Kiora Pharmaceuticals Inc (KPRX) stock
KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
$0.93−0.05 (-5.30%)
Close on Nov 17, 2026Market cap $4.11MP/E –Yield –
Kiora Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Kiora Pharmaceuticals's price to sales ratio was 390.1× on Jul 31, 2025, against 0.8× a year earlier. Over the last 5 years it ranged from 0.6× to 478.8×, with a median of 101.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jul 31, 2025 | 390.1× | +389.5 |
| 2024 | Dec 31, 2024 | 0.6× | −7.1 |
| 2020 | Apr 30, 2020 | 7.7× | −3.3 |
| 2019 | Dec 31, 2019 | 11.1× | −167.9 |
| 2018 | Dec 31, 2018 | 178.9× | −295.4 |
| 2017 | Dec 29, 2017 | 474.4× | +25.1 |
| 2016 | Dec 30, 2016 | 449.3× | – |
See a number that looks wrong?